The Food and Drug Administration Drug Shortage Division has reported that two companies, Hospira and Sandoz, are producing succinylcholine injections, according to an ASA report.
Succinylcholine is a paralytic drug used to induce muscle relaxation and short-term paralysis, usually to facilitate tracheal intubation. The two manufacturers are now able to manufacture enough succinylcholine to meet market demands.
This is a positive development for patients and physicians, considering an April 2011 ASA survey on drug shortages found that 47.6 percent of respondents were experiencing a shortage of succinylcholine.
Read the ASA release on succinylcholine.
Related Articles on Anesthesia:
Anesthesiologist Dr. Marshall Joins Joins North Dakota's Medcenter One
Florida Anesthesiologists Launch National Consulting Firm
Pennsylvania Anesthesiologist Pleads Guilty to Tax Case in Federal Court
Succinylcholine is a paralytic drug used to induce muscle relaxation and short-term paralysis, usually to facilitate tracheal intubation. The two manufacturers are now able to manufacture enough succinylcholine to meet market demands.
This is a positive development for patients and physicians, considering an April 2011 ASA survey on drug shortages found that 47.6 percent of respondents were experiencing a shortage of succinylcholine.
Read the ASA release on succinylcholine.
Related Articles on Anesthesia:
Anesthesiologist Dr. Marshall Joins Joins North Dakota's Medcenter One
Florida Anesthesiologists Launch National Consulting Firm
Pennsylvania Anesthesiologist Pleads Guilty to Tax Case in Federal Court